Recently, WIXBIO welcomed a delegation of key partner clients from Burkina Faso. The group made a special trip to tour and inspect WIXBIO’s R&D labs and production base, and were really impressed by the company’s breakthroughs in vaccine tech R&D.
In the R&D laboratory, the client delegation took a close look at WIXBIO’ self-developed vaccine platform technology, core antigen design, and immune optimization strategies. They were deeply impressed by the company’s innovative R&D capabilities and professional technical expertise.
After that, the delegation toured the modern production base. Built strictly to GMP standards, the facility let the clients closely examine the full vaccine production process, quality control systems, and cold chain capabilities. They highly recognized WIXBIO’ efficient production capacity and strict quality management.
During the discussion meeting, both sides had in-depth talks on vaccine technology cooperation and adapting products for the African market. The Burkina Faso clients said the visit strengthened their confidence in partnering with WIXBIO, noting that WIXBIO’ vaccine innovations would be a big boost to public health efforts across Africa.
This successful visit not only fully affirmed WIXBIO’s technological strength and global capabilities but also laid a solid foundation for deeper strategic cooperation between the two sides in the future.
WIXBIO will keep driving innovation and putting quality first, teaming up with global partners to contribute more Chinese biotech power for human health!
